The Medicare Part B mandatory demonstration project has sparked widespread concerns over its singular focus on drug costs, costs that oncologists do not—and cannot—control. Preliminary analysis conducted by ASCO suggests oncology practices will, on average, lose $30,000-$35,000 per physician FTE.
The Society is expanding its analyses and has developed an ASP Practice Modeling Tool for individual oncology practices to determine the real-life impact of the five-year Medicare Part B demonstration project. Practices are guided through a four-step process to review the Medicare portion of their businesses using data from the fourth quarter of 2015 under several different ASP scenarios. Participating practices are asked to share results with ASCO, which will aggregate the data to assess the impact of the Medicare demonstration on practices across the United States and inform future advocacy efforts on this critically important issue. (Practice names will be kept confidential),
Detailed instructions are available in the first tab of the ASP Practice Modeling Tool. For additional questions and to share results with ASCO, please email Elaine L. Towle, ASCO’s Director of Analysis and Consulting Services. Modeling results must be submitted no later than Friday, April 15.
Keep an eye on ASCO in Action, for further analysis, comments, and information as this issue unfolds.